Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Anna Kinderkrebsforschung
University of Birmingham
The Netherlands Cancer Institute
Roswell Park Cancer Institute
St. Anna Kinderkrebsforschung
The Netherlands Cancer Institute
University Hospital, Bonn